Dogs and Cats — Revenue
Zoetis Dogs and Cats — Revenue decreased by 9.0% to $1.44B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $1.48B to $1.44B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market demand and successful product adoption within the companion animal healthcare sector, while a decrease may signal increased competition or a slowdown in pet owner spending on veterinary services.
Detailed definition
This metric represents the total gross sales generated from products specifically designed for companion animals, includ...
Peer comparison
Comparable to companion animal health revenue segments reported by other major animal health and pharmaceutical companies, often benchmarked against broader pet industry growth trends.
zts_segment_dogs_and_cats_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.16B | $1.14B | $1.20B | $1.30B | $1.21B | $1.15B | $1.42B | $1.35B | $1.38B | $1.58B | $1.55B | $1.48B | $1.72B | $1.59B | $1.44B |
| QoQ Change | — | -1.6% | +5.0% | +8.7% | -6.9% | -4.9% | +23.5% | -4.9% | +2.2% | +14.2% | -1.9% | -4.5% | +15.9% | -7.6% | -9.0% |
| YoY Change | — | — | — | +12.2% | +6.2% | -3.8% | +9.3% | +11.6% | +20.0% | +11.0% | +14.5% | +7.0% | +8.5% | +2.3% | -2.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zoetis's dogs and cats — revenue?
- Zoetis (ZTS) reported dogs and cats — revenue of $1.44B in Q1 2026.
- How has Zoetis's dogs and cats — revenue changed year-over-year?
- Zoetis's dogs and cats — revenue decreased by 2.6% year-over-year, from $1.48B to $1.44B.
- What does dogs and cats — revenue mean?
- The total revenue generated from the sale of health products and diagnostics for dogs and cats.